Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193805-20-000562
Filing Date
2020-05-06
Accepted
2020-05-06 17:18:25
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 e619607_10q-adma.htm 10-Q 680599
2 e619607_ex31-1.htm EX-31.1 9413
3 e619607_ex31-2.htm EX-31.2 9418
4 e619607_ex32-1.htm EX-32.1 3459
5 e619607_ex32-2.htm EX-32.2 3453
  Complete submission text file 0001193805-20-000562.txt   2891497

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adma-20200331.xml EX-101.INS 459604
7 XBRL TAXONOMY EXTENSION SCHEMA adma-20200331.xsd EX-101.SCH 26486
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adma-20200331_cal.xml EX-101.CAL 54053
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adma-20200331_def.xml EX-101.DEF 53126
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20200331_lab.xml EX-101.LAB 216661
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20200331_pre.xml EX-101.PRE 173742
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36728 | Film No.: 20853655
SIC: 2836 Biological Products, (No Diagnostic Substances)